FI972950A0 - Plåster innehållande estradiol - Google Patents
Plåster innehållande estradiolInfo
- Publication number
- FI972950A0 FI972950A0 FI972950A FI972950A FI972950A0 FI 972950 A0 FI972950 A0 FI 972950A0 FI 972950 A FI972950 A FI 972950A FI 972950 A FI972950 A FI 972950A FI 972950 A0 FI972950 A0 FI 972950A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- date jul
- sec
- active substance
- pressure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19500662 | 1995-01-12 | ||
DE19500662A DE19500662C2 (de) | 1995-01-12 | 1995-01-12 | Estradiolhaltiges Pflaster und seine Verwendung |
PCT/EP1995/005005 WO1996021433A1 (de) | 1995-01-12 | 1995-12-18 | Estradiolhaltiges pflaster |
EP9505005 | 1995-12-18 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI972950A FI972950A (sv) | 1997-07-11 |
FI972950A0 true FI972950A0 (sv) | 1997-07-11 |
FI119358B FI119358B (sv) | 2008-10-31 |
Family
ID=7751307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI972950A FI119358B (sv) | 1995-01-12 | 1997-07-11 | Plåster innehållande estradiol |
Country Status (24)
Country | Link |
---|---|
US (1) | US5885612A (sv) |
EP (1) | EP0802789B1 (sv) |
JP (1) | JPH10511966A (sv) |
KR (1) | KR100373451B1 (sv) |
CN (1) | CN1172430A (sv) |
AT (1) | ATE181827T1 (sv) |
AU (1) | AU700697B2 (sv) |
CA (1) | CA2209711C (sv) |
CZ (1) | CZ288128B6 (sv) |
DE (2) | DE19500662C2 (sv) |
DK (1) | DK0802789T3 (sv) |
ES (1) | ES2137560T3 (sv) |
FI (1) | FI119358B (sv) |
GR (1) | GR3031397T3 (sv) |
HU (1) | HU226275B1 (sv) |
IL (1) | IL116614A (sv) |
MY (1) | MY132338A (sv) |
NO (1) | NO972565D0 (sv) |
NZ (1) | NZ297806A (sv) |
PL (1) | PL321188A1 (sv) |
SI (1) | SI0802789T1 (sv) |
SK (1) | SK281623B6 (sv) |
WO (1) | WO1996021433A1 (sv) |
ZA (1) | ZA96223B (sv) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19700913C2 (de) * | 1997-01-14 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Abgabe von Hormonen |
DE19830651A1 (de) * | 1998-07-09 | 2000-01-13 | Lohmann Therapie Syst Lts | Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung |
US6465004B1 (en) | 1999-06-05 | 2002-10-15 | Noven Pharmaceuticals, Inc. | Solubility enhancement of drugs in transdermal drug delivery systems and methods of use |
AU3104301A (en) | 2000-01-20 | 2001-07-31 | Noven Pharmaceuticals, Inc. | Compositions and methods to effect the release profile in the transdermal administration of active agents |
DE10025970C2 (de) * | 2000-05-25 | 2002-04-25 | Lohmann Therapie Syst Lts | Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung |
DE10025971B4 (de) * | 2000-05-25 | 2004-09-02 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung |
AU2002235155A1 (en) * | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
US7740481B2 (en) * | 2002-06-21 | 2010-06-22 | Politecnico Di Milano | Osteointegrative interface for implantable prostheses and a method for the treatment of the osteointegrative interface |
IT1390847B1 (it) | 2008-07-29 | 2011-10-19 | Milano Politecnico | Trattamento biomimetico a base silicio per l'osteointegrazione di substrati in metallo. |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US9353453B2 (en) | 2012-07-19 | 2016-05-31 | Politecnico Di Milano | Metal substrate modified with silicon based biomimetic treatment having antibacterial property for the osteointegration thereof |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
DE102018120506A1 (de) | 2017-10-20 | 2019-04-25 | Amw Gmbh | Stabilisiertes transdermales Darreichungssystem |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3637224A (en) * | 1969-02-27 | 1972-01-25 | Fedders Corp | Annular sealing ring |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
AU553343B2 (en) * | 1981-08-10 | 1986-07-10 | Advance Electrode Kabushikikaisya | Absorbent adhesive bandage with medicament release |
US4624665A (en) * | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
EP0186019B1 (de) * | 1984-12-22 | 1993-10-06 | Schwarz Pharma Ag | Wirkstoffpflaster |
US4883669A (en) * | 1985-02-25 | 1989-11-28 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration |
CN1021196C (zh) * | 1986-12-29 | 1993-06-16 | 新泽西州州立大学(鲁杰斯) | 透皮雌激素/孕激素药剂单元、系统及方法 |
CH674618A5 (sv) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
DE3743946A1 (de) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung |
DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
FR2635979B1 (fr) * | 1988-09-07 | 1992-05-29 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
US5518734A (en) * | 1991-09-25 | 1996-05-21 | Beta Pharmaceuticals Co. | Transdermal delivery system for estradiol and process for manufacturing said device |
DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
DE4336557C2 (de) * | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
US5503844A (en) * | 1993-05-18 | 1996-04-02 | Mli Acquisition Corp. Ii | Foam laminate transdermal patch |
-
1995
- 1995-01-12 DE DE19500662A patent/DE19500662C2/de not_active Expired - Fee Related
- 1995-12-18 PL PL95321188A patent/PL321188A1/xx unknown
- 1995-12-18 EP EP95941722A patent/EP0802789B1/de not_active Expired - Lifetime
- 1995-12-18 HU HU9800182A patent/HU226275B1/hu not_active IP Right Cessation
- 1995-12-18 JP JP8521396A patent/JPH10511966A/ja active Pending
- 1995-12-18 SK SK952-97A patent/SK281623B6/sk unknown
- 1995-12-18 US US08/860,595 patent/US5885612A/en not_active Expired - Lifetime
- 1995-12-18 NZ NZ297806A patent/NZ297806A/en unknown
- 1995-12-18 ES ES95941722T patent/ES2137560T3/es not_active Expired - Lifetime
- 1995-12-18 DK DK95941722T patent/DK0802789T3/da active
- 1995-12-18 WO PCT/EP1995/005005 patent/WO1996021433A1/de active IP Right Grant
- 1995-12-18 DE DE59506370T patent/DE59506370D1/de not_active Expired - Lifetime
- 1995-12-18 SI SI9530313T patent/SI0802789T1/xx unknown
- 1995-12-18 AU AU43050/96A patent/AU700697B2/en not_active Ceased
- 1995-12-18 KR KR1019970704778A patent/KR100373451B1/ko not_active IP Right Cessation
- 1995-12-18 CA CA002209711A patent/CA2209711C/en not_active Expired - Fee Related
- 1995-12-18 CN CN95197296A patent/CN1172430A/zh active Pending
- 1995-12-18 AT AT95941722T patent/ATE181827T1/de active
- 1995-12-18 CZ CZ19972121A patent/CZ288128B6/cs not_active IP Right Cessation
- 1995-12-29 IL IL11661495A patent/IL116614A/xx not_active IP Right Cessation
-
1996
- 1996-01-08 MY MYPI96000055A patent/MY132338A/en unknown
- 1996-01-11 ZA ZA96223A patent/ZA96223B/xx unknown
-
1997
- 1997-06-05 NO NO972565A patent/NO972565D0/no not_active Application Discontinuation
- 1997-07-11 FI FI972950A patent/FI119358B/sv not_active IP Right Cessation
-
1999
- 1999-09-30 GR GR990402488T patent/GR3031397T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI972950A0 (sv) | Plåster innehållande estradiol | |
ES2174922T3 (es) | Potenciador de la penetracion de estradiol para administracion transdermica. | |
DK0697860T3 (da) | Estradiolholdigt transdermalt terapeutisk system | |
CA2338859A1 (en) | Estradiol-containing patch for transdermal administration of hormones | |
AU687775B2 (en) | Nitroglycerine-containing plaster, process for producing the same and its uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 119358 Country of ref document: FI |
|
MM | Patent lapsed |